Tower Research Capital (TRC)’s Seelos Therapeutics, Inc. Common Stock SEEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-95
| Closed | -$357 | – | 6169 |
|
|
2024
Q3 | $357 | Sell |
95
-146
| -61% | -$549 | ﹤0.01% | 5364 |
|
|
2024
Q2 | $2.3K | Buy |
241
+159
| +194% | +$1.52K | ﹤0.01% | 5027 |
|
|
2024
Q1 | $6.22K | Buy |
82
+41
| +100% | +$3.11K | ﹤0.01% | 4409 |
|
|
2023
Q4 | $7.34K | Buy |
+41
| New | +$7.34K | ﹤0.01% | 4624 |
|
|
2023
Q3 | – | Sell |
-2
| Closed | -$10.1K | – | 6306 |
|
|
2023
Q2 | $10.1K | Buy |
+2
| New | +$10.1K | ﹤0.01% | 4152 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 5654 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 6515 |
|
|
2022
Q3 | – | Sell |
-2
| Closed | -$6K | – | 6604 |
|
|
2022
Q2 | $6K | Sell |
2
-2
| -50% | -$6K | ﹤0.01% | 4980 |
|
|
2022
Q1 | $14K | Sell |
4
-4
| -50% | -$14K | ﹤0.01% | 3931 |
|
|
2021
Q4 | $48K | Buy |
8
+5
| +167% | +$30K | ﹤0.01% | 2797 |
|
|
2021
Q3 | $26K | Hold |
3
| – | – | ﹤0.01% | 3497 |
|
|
2021
Q2 | $29K | Sell |
3
-1
| -25% | -$9.67K | ﹤0.01% | 3544 |
|
|
2021
Q1 | $76K | Buy |
+4
| New | +$76K | ﹤0.01% | 2798 |
|
|
2020
Q4 | – | Hold |
0
| – | -$2K | – | 5467 |
|
|
2020
Q3 | – | Sell |
-2
| Closed | -$8K | – | 4630 |
|
|
2020
Q2 | $8K | Buy |
+2
| New | +$8K | ﹤0.01% | 4130 |
|
|
2016
Q2 | – | Hold |
0
| – | – | – | 5092 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 5104 |
|
|
2015
Q4 | – | Hold |
0
| – | – | – | 5176 |
|
|
2015
Q3 | – | Hold |
0
| – | – | – | 4981 |
|
|
2015
Q2 | – | Hold |
0
| – | -$9K | – | 5188 |
|
|
2015
Q1 | – | Hold |
0
| – | – | – | 2885 |
|
|
2014
Q4 | – | Hold |
0
| – | -$12K | – | 4827 |
|
|
2014
Q3 | – | Hold |
0
| – | -$2K | – | 2717 |
|
|
2014
Q2 | – | Hold |
0
| – | – | – | 3477 |
|
|
2014
Q1 | – | Hold |
0
| – | -$5K | – | 5071 |
|
|
2013
Q4 | – | Hold |
0
| – | -$3K | – | 3552 |
|
|
2013
Q3 | – | Hold |
0
| – | – | – | 3985 |
|